Overview of data collection methods and targeted minimum numbers
| Tools | Data source | Content | Minimum numbers | Time period | Responsible for data collection | Data collection technique |
| IDI-providers | Service providers: TB doctor, TB nurse, family doctor, rural doctor, rural nurse | Personnel perspectives | 40 (5 interviews/site) | One year after the intervention start | Researchers | Face-to-face interview (IDI guides) |
| IDI-facility managers | Facility manager, clinical manager | Managers perspectives | 16 (2 interviews/site) | One year after the intervention start | Researchers | Face-to-face interview (IDI guides) |
| IDI-TB coordinator | TB coordinator | TB coordinators views | 5 | One year after the intervention start | Researchers | Face-to-face interview (IDI guides) |
| IDI-patients | Patient | Patients perspectives | 48 (3 DS+3 DR patients per site) | One year after the intervention start | Researchers | Face-to-face interview (IDI guides) |
| IDI-national level respondents | MoLHSA, National Centre for Disease Control, the Global Fund, TB programme, Social Service Agency | National-level key actors’ perspectives | 5 interviews | 15 months after the intervention start | Researchers | Face-to-face interview (IDI guides) |
| IDI-network HQ | Top managers from each network | Network specific views | 3 interviews | One year after the intervention start | Researchers | Face-to-face interview (IDI guides) |
| Non-participant observation of consultations | TB unit | TB consultations | 24 (2 DS patient+1 DR patient per facility) (Patients who are interviewed) | One year after the intervention start | Researchers | Observation |
| Non-participant observation of integrated team meetings | Facility | Integrated team meetings | 15 (3 per facility in intervention sites only) | 1 observation per site at beginning, mid-term, and near end | Researchers | Observation |
| Local context mapping tool | Managers | Conditions for intervention implementation | First 2 months and 1 year after the intervention start | Researchers | Face-to-face interview (IDI guide)+informal observations | |
| National context mapping tool | Policy makers | Conditions for intervention implementation | Continuous | Researchers | Face-to-face interview (IDI guide)+informal observations+meetings with in the CIF team |
DR, drug sensitive; DS, drug resistant; HQ, headquarters; IDI, in-depth interview; MoLHSA, Ministry of Labour, Health and Social Affairs; TB, tuberculosis.